Surgical Treatment of Hydatid Liver Disease

The goal of this observational study is to show that cyst extraction with pericyst reduction and omentopexy is a suitable treatment for liver hydatid disease caused by E.Granulossus with a low rate of complication and recurrence.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hydatid Cyst, Hepatic Cestode Infections Digestive System Diseases Echinococcosis Echinococcosis, Hepatic Helminthiasis Infections Liver Diseases Liver Diseases, Parasitic Parasitic Diseases

Age range

16 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Elena Zafirovikj

Skopje, 1000, North Macedonia

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

hydatid liver disease

Exclusion criteria

hydatid disease present outside the liver

Treatment and study plan

Primary outcomes

Post operative complications

Time frame: one month

Listing of complications according to Clavien -Dindo classification

Secondary outcomes

Recurrence rate

Time frame: 5 years

Recurrence rate of hydatid disease in patients

Sponsors and collaborators

Lead sponsor

University Hospital for Surgical Diseases St. Naum Ohridsk i- Skopje

Other

Registry information

Official study title

Cyst Extraction With Pericyst Reduction and Omentopexy as a Treatment of Choice for Hydatid Liver Disease Caused by E. Granulosus: Retrospective Observational Review of a Single Center Experience

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2023
First posted: Aug 14, 2023
Registry last updated: Aug 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed